Prescription drug giant GlaxoSmithKline agreed to pay a record $3 billion fine to settle a litany of charges stemming from the company's illegal promotion of its products. Among other criminal complaints, federal prosecutors had accused GlaxoSmithKline of promoting the anti-depression drug Paxil for children, even though the FDA had never approved Paxil for patients under 18. GlaxoSmithKline was also accused of bribing physicians to prescribe its products, part of a web of mutual back-scratching that critics say has compromised the prescription drug market.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- 10 things you need to know today: September 30, 2014
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- 43 TV shows to watch in 2014
- The troubling persistence of eugenicist thought in modern America
- How liberals are unwittingly paving the way for the legalization of adult incest
- Libertarianism's terrible, horrible, no good, very bad idea
- 6 things the happiest families all have in common
- What the Romney boomlet says about the establishment GOP's feeble 2016 field
- How the Simpsons/Family Guy crossover revealed the worst of both shows
- Eric Holder blew it as attorney general. His replacement will, too,
Subscribe to the Week